NET PROFIT (x1000 DKK)
EMPLOYEES
Scanpharm A/S
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-4,425
|
-6,106
|
-10,785 |
Total assets |
31,602
|
29,659
|
28,911 |
Current assets |
17,560
|
16,126
|
14,594 |
Current liabilities |
26,476
|
25,252
|
23,465 |
Equity capital |
1,500
![]() |
1,500
![]() |
1,500 |
- share capital |
3,000
![]() |
3,000
![]() |
3,000 |
Employees (average) |
75
![]() |
75
![]() |
75 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
4.7%
|
5.1%
|
5.2% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
66.3%
|
63.9%
|
62.2% |
Return on equity (ROE) |
-295.0%
|
-407.1%
|
-719.0% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.